What are the treatment options for psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psoriasis Treatment Options

Topical corticosteroids combined with vitamin D analogs are the first-line treatment for mild to moderate psoriasis, while phototherapy, methotrexate, or biologics are recommended for moderate to severe disease. 1

Treatment Algorithm Based on Disease Severity

Mild Psoriasis (<3% Body Surface Area)

  • First-line therapy: Combination of topical corticosteroid + vitamin D analog (calcipotriene/calcipotriol) 1
    • Start with moderate potency (Class III) corticosteroids for most body areas
    • Use low potency (Class VI-VII) for face, genitals, and intertriginous areas
    • Consider tacrolimus 0.1% ointment for face and genital regions 1
  • If inadequate response after 4 weeks:
    • Consider adding tazarotene or switching to higher potency corticosteroid 1
    • Coal tar preparations (0.5-1.0% concentration, can increase to 10%) 2, 1

Moderate Psoriasis (3-10% Body Surface Area)

  • First-line therapy: Potent topical therapies as above
  • If inadequate response after 4-8 weeks:
    • Phototherapy (narrowband UVB 2-3 times weekly for 20-30 sessions) 1
    • Consider adding topical calcipotriene to methotrexate (7.5-25 mg weekly) 2, 1

Severe Psoriasis (>10% Body Surface Area)

  • First-line options:
    • Phototherapy (narrowband UVB or PUVA) 1
    • Methotrexate (7.5-25 mg weekly) 1
    • Biologics (adalimumab, infliximab, ustekinumab) 1, 3
    • Cyclosporine (3-5 mg/kg/day for short courses of 3-4 months) 1
  • For enhanced efficacy: Consider combination therapies 1
    • Class 1 topical corticosteroid + etanercept 2
    • Calcipotriene/betamethasone + adalimumab 2

Special Formulations for Specific Areas

Scalp Psoriasis

  • Medicated shampoos containing coal tar, salicylic acid
  • Solutions or foams of corticosteroids or vitamin D analogs 1

Inverse Psoriasis (Intertriginous Areas)

  • Low potency corticosteroids
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) 1, 4

Nail Psoriasis

  • Potent topical corticosteroids
  • Intralesional corticosteroids
  • Consider systemic therapy if severe 1

Alternative Medicine Options

  • Traditional Chinese medicine including herbal methods (only if ingredients are known and well understood)
  • Acupuncture (responses relatively minor) 2

Important Considerations and Precautions

  • Corticosteroid safety: Use the lowest effective potency, particularly in sensitive areas and in children 1, 5

    • Risk of skin atrophy, telangiectasia, and striae with prolonged use
    • Consider weekend-only or every-other-day application for maintenance 4
  • Vitamin D analogs: Maximum 100g per week to avoid hypercalcemia 1

  • Biologic therapy precautions: Screen for tuberculosis before initiating therapy 1, 3

    • Monitor for serious infections during treatment
    • Discontinue if serious infection develops 3
  • Medication interactions: Certain medications can worsen psoriasis, including alcohol, beta-blockers, NSAIDs, lithium, and antimalarials 1

  • Treatment adherence: Patient education on proper application techniques is essential 1

  • Regular monitoring: Assess treatment response after 4 weeks and monitor for adverse effects 1

Psoriasis is a chronic condition requiring long-term management. The treatment approach should be adjusted based on disease severity, affected areas, and response to therapy. Combination therapies often provide enhanced efficacy while minimizing side effects of individual agents 2, 1, 6.

References

Guideline

Psoriasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2007

Research

Topical corticosteroids in psoriasis: strategies for improving safety.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.